---
figid: PMC8589460__IJMM-49-01-05056-g00
figtitle: Therapeutic strategies targeting Wnt/Beta-catenin signaling for colorectal
  cancer (Review)
organisms:
- Lareunionomyces loeiensis
- herbal medicine
- Aloe vera
- Scutellaria barbata
- Trichosanthes kirilowii
- Sanguisorba officinalis
- Aloe arborescens
- Magnolia obovata
- Lonchocarpus sericeus
- Salvia cavaleriei
- Aloe arborescens var. natalensis
- Mus musculus
- Rattus norvegicus
- Fusobacterium nucleatum
- Chlamydia trachomatis
- Homo sapiens
- Xenopus laevis
- Adenoviridae
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Xenopus laevis
pmcid: PMC8589460
filename: IJMM-49-01-05056-g00.jpg
figlink: /pmc/articles/PMC8589460/figure/f1-ijmm-49-01-05056/
number: F1
caption: 'Schematic illustration of the Wnt/β-catenin signaling pathway. (A) Inactive
  Wnt/β-catenin pathway: In the absence of Wnt ligands, GSK-3β and CK1 phosphorylate
  β-catenin for poly-ubiquitination by β-TrCP and subsequent proteasome-mediated degradation.
  (B) Active β-catenin pathway: In the presence of Wnt ligands, the formation of the
  destruction complex is affected, leading to the nuclear translocation of β-catenin.
  GSK-3β, glycogen synthase kinase-3β; CK1, casein kinase 1; β-TrCP, β-transducin
  repeats-containing protein.'
papertitle: Therapeutic strategies targeting Wnt/β-catenin signaling for colorectal
  cancer (Review).
reftext: Yong Ji, et al. Int J Mol Med. 2022 Jan;49(1):1.
year: '2022'
doi: 10.3892/ijmm.2021.5056
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: therapeutic strategy | Wnt | β-catenin | colorectal cancer
automl_pathway: 0.957952
figid_alias: PMC8589460__F1
figtype: Figure
redirect_from: /figures/PMC8589460__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8589460__IJMM-49-01-05056-g00.html
  '@type': Dataset
  description: 'Schematic illustration of the Wnt/β-catenin signaling pathway. (A)
    Inactive Wnt/β-catenin pathway: In the absence of Wnt ligands, GSK-3β and CK1
    phosphorylate β-catenin for poly-ubiquitination by β-TrCP and subsequent proteasome-mediated
    degradation. (B) Active β-catenin pathway: In the presence of Wnt ligands, the
    formation of the destruction complex is affected, leading to the nuclear translocation
    of β-catenin. GSK-3β, glycogen synthase kinase-3β; CK1, casein kinase 1; β-TrCP,
    β-transducin repeats-containing protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - PROC
  - CTNNB1
  - AXIN1
  - AXIN2
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - GSK3B
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CHKA
  - BTRC
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - ETV6
  - HNF4A
  - LRP6
  - LRP5
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - MYC
  - Apc
  - Ctnnb1
  - Axin1
  - Gsk3b
  - Btrc
  - Dvl1
  - Etv6
  - Lrp6
  - Lrp5
  - Myc
  - Nol3
  - di
  - Th
  - Wnt2
  - apc.L
  - ctnnb1.S
  - ctnnb1.L
  - axin1.S
  - gsk3b.L
  - gsk3b.S
  - csnk1g2.L
  - btrc.S
  - btrc.L
  - dvl2.L
  - dvl2.S
  - hdac3.S
  - lrp6.L
  - lrp6.S
  - lrp5.L
  - myc.S
  - myc.L
---
